European Pharmacopoeia 10th

PDF Free European Pharmacopoeia EP 10th edition download

The European Pharmacopoeia (Ph. Eur.) or simply EP 10 edition is a unique reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control throughout the life cycle of a product. These standards are legally binding, as established in the Council of Europe Convention on the preparation of a European Pharmacopoeia and in national and EU pharmaceutical legislation. Ph. Eur. Quality standards become mandatory on the same date in all States Parties to the convention and you can get PDF Free European Pharmacopoeia EP 10th edition with direct download of the google drive link

The tenth edition of the Ph. Eur. Was published in July 2019 and will be updated with eight periodic supplements over the next three years (10.1 to 10.8)

Name of Book European Pharmacopoeia EP
Author Council of Europe.; European Pharmacopoeia Commission.
Edition 10th
Format PDF
Volume 1
Category Pharmaceuticals

 

What is in 10th Edition:

It is legally binding in 39 European countries and applied in more than 120 countries around the world.
Provide new and revised texts.
It offers crucial information for European markets before any other pharmacopoeia.
The 10th edition (including Supplement 10.7) contains 2463 monographs (including dosage forms), 383 general texts (including general monographs and analytical methods), and approximately 2850 reagent descriptions. European Pharmacopoeia monographs.

 

More About EP 10the edition:

The European Pharmacopoeia PDF FREE is prepared under the auspices of the Council of Europe in accordance with the Convention on the elaboration of a European Pharmacopoeia (European Treaty Series No. 50) as amended by the Protocol to the Convention (European Treaty Series No. 134), signed by the Governments of 38 Member States (Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg , Malta, Montenegro, Netherlands, North Macedonia, Norway, Poland, Portugal, Republic of Moldova, Romania, Serbia, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom) and the European Union. The preparation of the Pharmacopoeia is the responsibility of the European Pharmacopoeia Commission (“the Commission”), designated in accordance with Article 5 of the aforementioned Convention. It is made up of delegations designated by the Contracting Parties. Each delegation is made up of no more than 3 members elected for their competence in matters within the functions of the Commission.

Observers from non-member states and international organizations are admitted to Commission Sessions in accordance with the Regulations. Observers from Albania, Algeria, Argentina, Armenia, Australia, Azerbaijan, Belarus, Brazil, Canada, China, Georgia, Guinea, India, Israel, Japan, Kazakhstan, Republic of Korea, Madagascar, Malaysia, Morocco, Russian Federation have currently supported Senegal, Singapore, South Africa, Syrian Arab Republic, Tunisia, United States of America, Uzbekistan, Taiwan Food and Drug Administration (TFDA) and the World Health Organization (WHO).

The Convention is open for signature by European countries and observer status can serve to familiarize European countries wishing to become signatories with the Commission’s working methods. The Commission recognizes that interactions with countries outside of Europe are essential in view of the globalization of the pharmaceutical supply chain. Observer status for non-European countries helps foster these interactions by facilitating regulatory associations and the exchange of information and working documents, as well as participation in the scientific work of the Commission. The tenth edition of the European Pharmacopoeia contains about 3000 monographs and general texts. This would not have been possible without the contributions and dedication of a network of more than 700 experts in pharmaceutical sciences from around the world. The involvement of experts and stakeholders in the public standard-setting process of the European Pharmacopoeia is vital for the development of authoritative and relevant monographs. You will also soon download other European Pharmacopoeia pdf latest edition pdf free

 

 
 

Leave a Reply

Your email address will not be published. Required fields are marked *